Dr. Alvarez is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12605 E 16th Ave
Aurora, CO 80045Phone+1 720-848-0000
Education & Training
Washington University/B-JH/SLCH ConsortiumResidency, Neurology, 2007 - 2010
University of ColoradoInternship, Internal Medicine, 2006 - 2007- University of Colorado School of Medicine Anschutz Medical CampusClass of 2006
Certifications & Licensure
CO State Medical License 2013 - 2025
MO State Medical License 2010 - 2014- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012
Clinical Trials
- Central Vein Sign: a Diagnostic Biomarker in Multiple Sclerosis Start of enrollment: 2020 Sep 11
Publications & Presentations
PubMed
- 59 citationsDistinguishing between Fatigue and Fatigability in Multiple SclerosisRoger M. Enoka, Awad M. Almuklass, Mohammed Alenazy, Enrique Alvarez, Jacques Duchateau
Neurorehabilitation and Neural Repair. 2021-09-28 - 16 citationsSubjective cognitive concern in multiple sclerosis is associated with reduced thalamic and cortical gray matter volumes.Isaiah Kletenik, Enrique Alvarez, Justin M. Honce, Brooke Valdez, Timothy Vollmer
Multiple Sclerosis Journal - Experimental, Translational and Clinical. 2019-02-13 - 21 citationsPrognostic Value of Serum Neurofilament Light Chain for Disease Activity and Worsening in Patients With Relapsing Multiple Sclerosis: Results From the Phase 3 ASCLEPIO...Tjalf Ziemssen, Douglas L Arnold, Enrique Alvarez, Anne H Cross, Roman Willi
Frontiers in Immunology. 2022-01-01
Press Mentions
Anti-CD20 HGG Linked to Serious Infection Risk in MSJune 7th, 2024- New Scientific Advisory Board Member Dr. Enrique Alvarez on DMTs, Mobility, and MS ProgressionMarch 19th, 2024
- Study: Multiple Sclerosis Blood Antibodies Found to Be Toxic to NeuronsApril 25th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
